These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27836482)

  • 21. Pharmacists need recognition as providers to enhance patient care.
    White CM
    Ann Pharmacother; 2014 Feb; 48(2):268-73. PubMed ID: 24259647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which Comes First--Credentialing and Privileging in Pharmacy or Pharmacist Provider Status?
    Bradley-Baker L
    Am J Pharm Educ; 2014 Nov; 78(9):158. PubMed ID: 26056397
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacist compensation for ambulatory patient care services.
    Bradberry JC; Srnka Q
    Am J Manag Care; 1998 Dec; 4(12):1727-35; quiz 1736-7. PubMed ID: 10339105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicaid: Medicaid: provider reimbursement--2005. End of Year Issue Brief.
    Johnson P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-11. PubMed ID: 16710912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third party reimbursement for pharmacist services: why has it been so difficult to obtain and is it really the answer for pharmacy?
    Ganther JM
    J Am Pharm Assoc (Wash); 2002; 42(6):875-9. PubMed ID: 12482013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing pathways for access to pharmacist-provided patient care.
    Schommer JC; Doucette WR; Planas LG
    J Am Pharm Assoc (2003); 2015; 55(6):664-668. PubMed ID: 26547600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of the duty to warn--one state's experience.
    Williams KG
    J Pharm Technol; 1993; 9(4):146-9. PubMed ID: 10128044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
    Lounsbery JL; Green CG; Bennett MS; Pedersen CA
    J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. California bill would accord pharmacists provider status.
    Thompson CA
    Am J Health Syst Pharm; 2013 May; 70(10):839-40. PubMed ID: 23640341
    [No Abstract]   [Full Text] [Related]  

  • 30. Collaborative drug therapy management services and reimbursement in a family medicine clinic.
    Kuo GM; Buckley TE; Fitzsimmons DS; Steinbauer JR
    Am J Health Syst Pharm; 2004 Feb; 61(4):343-54. PubMed ID: 15011762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacists' perceptions of pay for performance versus fee-for-service remuneration for the management of hypertension through pharmacist prescribing.
    Rosenthal MM; Desai N; Houle SKD
    Int J Pharm Pract; 2017 Oct; 25(5):388-393. PubMed ID: 28097711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.
    Rodriguez MI; McConnell KJ; Swartz J; Edelman AB
    J Am Pharm Assoc (2003); 2016; 56(5):521-6. PubMed ID: 27594105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacists expand access to reproductive heaLthcare: PEARL study protocol.
    Rodriguez MI; Darney BG; Edelman AB; Yee K; Anderson LB; McConnell KJ
    BMC Health Serv Res; 2019 Apr; 19(1):207. PubMed ID: 30935394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significantly expanded anti-markup rule goes into effect January 1, 2009.
    Reisman G; Wool H; Chananie S; Finnegan J
    J Am Coll Radiol; 2009 Jan; 6(1):58-60. PubMed ID: 19111273
    [No Abstract]   [Full Text] [Related]  

  • 35. HCFA clarifies 'incident-to' billing by pharmacists.
    Am J Health Syst Pharm; 2000 Sep; 57(17):1557-8. PubMed ID: 10984801
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of suicide prevention programs and training policies for pharmacists.
    Carpenter DM; Lavigne JE; Roberts CA; Zacher J; Colmenares EW
    J Am Pharm Assoc (2003); 2018; 58(5):522-529. PubMed ID: 30017371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the cost of the Medicare Pharmacist Services Coverage Act of 2001.
    Poole VH; Moran DW; Webb CE
    Pharmacotherapy; 2003 Aug; 23(8):955-65. PubMed ID: 12921241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The outlook for pharmacist initiation and modification of drug therapy.
    Shefcheck SL; Thomas J
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):597-604. PubMed ID: 8908936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Granting and revocation of billing approvals in radiology according to § 135 para 2 SGB V].
    Steinhäuser RT; Wigge P
    Rofo; 2012 Sep; 184(9):848-51. PubMed ID: 22945682
    [No Abstract]   [Full Text] [Related]  

  • 40. Bipartisan, bicameral bill would add pharmacist services to Medicare.
    Thompson CA
    Am J Health Syst Pharm; 2015 Mar; 72(6):426-7. PubMed ID: 25736931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.